Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,345,634
-$2,288,604 QoQ
Shares Held
1,178,762
-11.1% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Derivatives in GRFS
reported options exposure · as of Mar 31, 2024CallValue
$907,812
CallShares
135,900
PutValue
$733,464
PutShares
109,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,652,960 | $9,179,190,573 | |
| 2 | JNJ |
Johnson & Johnson
|
19,722,544 | $5,008,934,496 | |
| 3 | ABBV |
AbbVie Inc.
|
16,291,630 | $4,099,625,769 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,075,139 | $2,836,655,359 | |
| 5 | AZN |
Astrazeneca PLC
|
9,742,396 | $1,847,353,128 | |
| 6 | AMGN |
Amgen Inc
|
4,130,732 | $1,495,820,670 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,778,294 | $1,361,729,661 | |
| 8 | PFE |
Pfizer Inc
|
52,991,850 | $1,276,043,746 |
All Filings in GRFS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,345,634 | 1,178,762 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,634,238 | 1,325,965 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,497,790 | 1,443,614 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $8,128,325 | 816,097 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,683,203 | 628,673 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,947,547 | 4,212,032 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $30,738,545 | 4,131,525 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $40,072,730 | 4,512,695 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $19,088,532 | 3,025,124 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $733,464 | 109,800 | Put | Defined | 2024-05-15 | |
| 2024-03-31 | $21,136,701 | 3,164,177 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $907,812 | 135,900 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $9,723,763 | 841,156 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $8,015,487 | 876,968 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $13,391,526 | 1,461,957 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $7,330,084 | 994,584 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,995,874 | 705,397 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $12,905,870 | 2,095,109 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $36,221,750 | 3,048,969 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $16,040,493 | 1,373,330 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,585,362 | 1,922,116 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $43,776,951 | 2,996,369 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $53,965,249 | 3,110,389 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $81,445,098 | 4,710,532 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $57,193,577 | 3,101,604 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $21,914,038 | 1,263,057 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $19,536,480 | 1,071,079 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $20,295,278 | 1,007,710 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||